GenScript Biotech's MSCI Environmental, Social, and Governance (ESG) rating has been improved to AA, acknowledging the company's status as a global front-runner in the industry.

GenScript Biotech's MSCI Environmental, Social, and Governance (ESG) rating has been improved to AA, acknowledging the company's status as a global front-runner in the industry.

GenScript Biotech Corporation, a prominent player in the biotech industry, has recently gained global recognition for its sustainability initiatives. The company has been upgraded to an AA ESG rating by MSCI, a global index provider that evaluates companies on ESG risks and management[1][2]. This rating recognizes GenScript as an ESG leader on a global scale.

The AA rating is not the only accolade GenScript has received. The company has also been awarded a Silver Medal from EcoVadis and a "Low Risk" ESG rating from Morningstar Sustainalytics[2]. These achievements underscore GenScript's commitment to integrating environmental, social, and governance (ESG) principles into its core business operations, driving sustainable growth and resilience worldwide.

GenScript's excellence was noted in the areas of product safety & quality, human capital development, environment, and governance practices. The company's dedication to sustainability is further reiterated by its participation in the United Nations Global Compact (UNGC), where it adheres to the ten universal principles on human rights, labor, environment, and anti-corruption[1][2].

In addition to these achievements, GenScript Biotech Corporation has been included in the FTSE4Good Index Series, recognizing its adherence to responsible business practices and ethical standards[1][2]. The company has also validated its carbon reduction targets by the Science Based Targets initiative (SBTi), demonstrating strong climate action commitments[1][2].

As a supplier partner of the Pharmaceutical Supply Chain Initiative (PSCI), GenScript is driving sustainable value chains for the pharmaceutical industry[2]. This commitment to sustainability reflects GenScript’s mission to "Make People and Nature Healthier Through Biotechnology," aligning business growth with environmental stewardship and social responsibility[1][3].

For future sustainable growth, GenScript is focused on embedding sustainability deeply into its business to enhance operational resilience and create long-term stakeholder value[1]. The company is also planning to expand its global footprint with investments in operations and production capacity, especially in the U.S. and Singapore, aligning growth with sustainability goals[3].

To learn more about GenScript Biotech Corporation and its sustainability initiatives, visit its official website at https://www.genscript.com. The press release, titled "GenScript Biotech's MSCI ESG Rating Upgraded to AA, Recognized as a Global Leader," can be viewed in full at https://www.prnewswire.com/news-releases/genscript-biotechs-msci-esg-rating-upgraded-to-aa-recognized-as-a-global-leader-302519342.html.

[1] GenScript Biotech Corporation. (2023). Sustainability at GenScript. [Online] Available at: https://www.genscript.com/about-us/sustainability

[2] Cision PR Newswire. (2023). GenScript Biotech's MSCI ESG Rating Upgraded to AA, Recognized as a Global Leader. [Online] Available at: https://www.prnewswire.com/news-releases/genscript-biotechs-msci-esg-rating-upgraded-to-aa-recognized-as-a-global-leader-302519342.html

[3] GenScript Biotech Corporation. (2023). News & Events. [Online] Available at: https://www.genscript.com/news-events

The AA ESG rating from MSCI and the Silver Medal from EcoVadis, along with the "Low Risk" ESG rating from Morningstar Sustainalytics, acknowledge GenScript's commitment to integrating ESG principles in its core operations, leveraging technology to drive sustainable growth and resilience globally. GenScript's active participation in initiatives like the United Nations Global Compact (UNGC) and the Pharmaceutical Supply Chain Initiative (PSCI) highlight its dedication to sustainable value chains and environmental stewardship, propelling cloud-based and technology-driven advancements in the biotech industry.

Read also: